On 17 May, Gapbridge Institute for Research and Consultancy joins the global community in commemorating World Hypertension Day 2026. This day is a reminder that hypertension remains one of the most serious public health challenges of our time, affecting families, communities, and health systems across the world.
Hypertension is often called the “silent killer” because many people live with high blood pressure without knowing it. It increases the risk of heart disease, stroke, kidney disease, and premature death.
For Somalia and many low- and middle-income countries, this day is especially important. The burden of noncommunicable diseases is increasing, while many people still face barriers to early screening, diagnosis, treatment, and long-term follow-up. World Hypertension Day is therefore not only a day of awareness — it is a call to strengthen primary health care, improve community screening, and promote prevention at every level.
Linking Hypertension, Maternal Health, and Pre-eclampsia
This year, Gapbridge Institute highlights the important connection between hypertension, maternal health, and pre-eclampsia. Pre-eclampsia is a high blood pressure disorder that typically develops after 20 weeks of pregnancy and can pose serious risks to both the mother and baby. Early detection and management are essential to prevent severe complications, including eclampsia, which can be life-threatening. (World Health Organization)
Pre-eclampsia should not be seen only as a pregnancy complication. It is also a warning sign for women’s long-term health. Women who experience hypertension during pregnancy may need continued follow-up after delivery to monitor blood pressure, reduce cardiovascular risk, and connect them to appropriate NCD services.
This creates a powerful opportunity: maternal health services can become an entry point for NCD prevention. Antenatal care visits should include routine blood pressure measurement, urine protein testing, counseling, referral for high-risk cases, and postpartum follow-up for women who experienced pregnancy-related hypertension.
Our Solidarity and Commitment
On World Hypertension Day 2026, Gapbridge Institute for Research and Consultancy stands in solidarity with:
- Health workers providing screening, counseling, and treatment in communities and health facilities.
- Pregnant women and mothers affected by pre-eclampsia, chronic hypertension, and other pregnancy-related complications.
- Families supporting loved ones living with hypertension and other NCDs.
- Policy makers, researchers, civil society organizations, and partners working to strengthen prevention and care.
We reaffirm our commitment to supporting evidence-based research, health system strengthening, community awareness, and practical solutions that improve prevention, early detection, and management of hypertension and other NCDs.
📣 Call to Action
To mark World Hypertension Day, Gapbridge Institute calls for stronger action to:
- Expand community-based blood pressure screening and NCD risk assessment.
- Integrate hypertension screening into antenatal, postnatal, and primary health care services.
- Strengthen referral pathways for pregnant women with high blood pressure and proteinuria.
- Promote healthy lifestyles, including reduced salt intake, physical activity, healthy diets, tobacco avoidance, and regular health checks.
- Ensure women with pre-eclampsia receive postpartum follow-up and long-term NCD prevention support.
- Invest in research and data systems to better understand the burden of hypertension and improve decision-making.
💡 Key Message
Hypertension can be prevented, detected, treated, and controlled. By linking NCD screening with maternal health services, Somalia can protect women during pregnancy and reduce their future risk of chronic hypertension, heart disease, stroke, and kidney disease.
On this World Hypertension Day, Gapbridge Institute calls on everyone to take one simple but powerful step:
Protect your heart. Protect mothers. Prevent NCDs.